STAAR Surgical Company (STAA)

STAAR Surgical Company Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	322.42	284.39	230.47	163.46	150.19
Revenue Growth (YoY)	13.37%	23.40%	41.00%	8.84%	21.16%
Cost of Revenue	69.76	61.01	51.84	45.1	38.23
Gross Profit	252.65	223.38	178.64	118.36	111.95
Selling, General & Admin	180.15	143.6	111.44	79.68	74.8
Research & Development	44.4	35.98	33.86	31.92	25.3
Operating Expenses	224.55	179.58	145.3	111.59	100.1
Operating Income	28.1	43.8	33.34	6.77	11.85
Interest Expense / Income	-6.99	-2.45	0.04	-0.24	-0.99
Other Expense / Income	1.39	0.7	2	-1.26	-0.19
Pretax Income	33.7	45.55	31.3	8.27	13.03
Income Tax	12.35	5.89	3.79	2.35	-1.02
Net Income	21.35	39.67	27.51	5.91	14.05
Net Income Growth	-46.18%	44.18%	365.26%	-57.91%	182.77%
Shares Outstanding (Basic)	49	48	47	46	44
Shares Outstanding (Diluted)	49	49	49	48	47
Shares Change	0.10%	-0.15%	3.13%	2.26%	3.62%
EPS (Basic)	0.44	0.83	0.58	0.13	0.32
EPS (Diluted)	0.43	0.80	0.56	0.12	0.30
EPS Growth	-46.25%	42.86%	366.67%	-60.00%	172.73%
Free Cash Flow	-3.59	17.61	30.32	12.55	15.7
Free Cash Flow Per Share	-0.07	0.37	0.64	0.28	0.35
Gross Margin	78.36%	78.55%	77.51%	72.41%	74.54%
Operating Margin	8.71%	15.40%	14.47%	4.14%	7.89%
Profit Margin	6.62%	13.95%	11.94%	3.62%	9.35%
Free Cash Flow Margin	-1.11%	6.19%	13.15%	7.68%	10.45%
Effective Tax Rate	36.65%	12.92%	12.12%	28.47%	-7.85%
EBITDA	31.83	47.61	34.98	11.12	15.74
EBITDA Margin	9.87%	16.74%	15.18%	6.81%	10.48%
Depreciation & Amortization	5.12	4.51	3.64	3.1	3.7
EBIT	26.71	43.1	31.34	8.03	12.04
EBIT Margin	8.28%	15.16%	13.60%	4.91%	8.02%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).